Riskpilot← Back to searchSign inGet full accessNMD medical AB
ABBankruptOrg 5592533029Temporary employment agency activities and other human resource provisions · NACE 7820Est. 20204 employees
Revenue 2022
SEK 2,8M
-90% vs 2021
EBITDA margin
21.3%
+118% vs 2021
Equity ratio
-174.3%
Financial strength
Net profit 2022
SEK 547K
+124% vs 2021
| Revenue | SEK 2,8M | -90% |
| EBITDA | SEK 592K | +118% |
| Net profit | SEK 547K | +124% |
| Total assets | SEK 932K | -56% |
| Equity | SEK -1,6M | +25% |
| Employees | 4 | — |
Legal name
NMD medical AB
Org number
5592533029
Legal form
Aktiebolag
NACE code
7820 · Temporary employment agency activities and other human resource provisions
Founded
23 april 2020
Share capital
SEK 25 000
Employees
4 (FTE)
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Import, export och försäljning både i parti- och detaljhandel av skönhetsprodukter och kosmetik. Högkvalitativa skönhetsbehandlingar med kosmetika, hår och hud inom olika områden. Utbildning i skönhetsbehandlingar och kosmetik.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 |
|---|---|---|---|
| Revenue | 7 655 | 28 980 | 2 779 |
| Staff expenses | — | −1 269 | −416 |
| EBITDA | 111 | −3 260 | 592 |
| Depreciation & amort. | −3 | −12 | −25 |
| EBIT | 108 | −3 272 | 567 |
| Net financials | — | −9 | −20 |
| Profit before tax | 107 | −2 281 | 547 |
| Tax | −24 | — | — |
| Net profit | 83 | −2 281 | 547 |
| Item | 2020 | 2021 | 2022 |
|---|---|---|---|
| Total assets | 3 753 | 2 098 | 932 |
| Equity | 108 | −2 173 | −1 625 |
| Long-term debt | 5 | 1 208 | 0 |
| Short-term debt | 3 641 | 3 063 | 2 558 |
| Total debt | 3 646 | 4 270 | 2 558 |
EBITDA margin
21.3%
This company
15.8%
Market median
+35% vs market
20202022
Equity ratio
-174.3%
This company
38.2%
Market median
-556% vs market
20202022
Return on equity
54745100.0%
This company
18.4%
Market median
+297527617% vs market
20202022
Net profit margin
19.7%
This company
8.1%
Market median
+143% vs market
20202022
Asset turnover
2.98×
This company
1.12×
Market median
+166% vs market
20202022
Debt / equity
1.57×
This company
0.62×
Market median
-153% vs market
20202022
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KA Chief Executive Officer | Chief Executive Officer | 2020 |
| Former (1) | ||
HA Chief Executive Officer | Chief Executive Officer | 2021 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2020 | |
| Former (2) | ||
| Board of Directors | 2021 – 2022 | |
| Deputy Board Member | 2021 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of NMD medical AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kodra Al Hir | Chief Executive Officer | 0 companies |
| Hassan Ali Kadhum | Chief Executive Officer | 0 companies |
| Mona Hadad | Board of Directors | 0 companies |
| Salah Mahdi Hussein Hussein | Deputy Board Member | 0 companies |
| Monaf Hadad | Deputy Board Member | 0 companies |